35 Epizód

  1. Episode 14: A Quantum Leap in AML Treatment? Dissecting Quizartinib Data with Dr. Dale Bixby

    Közzétéve: 2023. 05. 09.

  2. Episode 13: You get blinatumomab! You get blinatumomab!

    Közzétéve: 2023. 02. 24.

  3. Episode 12: Tinder for T Cells - Bispecifics in DLBCL

    Közzétéve: 2023. 02. 08.

  4. Episode 11: "Olu the Drunk Snowman" - IDH inhibitors in R/R AML with Dr. Jill Lykon

    Közzétéve: 2023. 01. 21.

  5. Episode 10: ASH Recap Part 2 - Papa Heme + WolverHeme

    Közzétéve: 2022. 12. 21.

  6. Episode 9: ASH Recap Part 1 - Dauno-Double Trouble

    Közzétéve: 2022. 12. 14.

  7. Episode 8: Pulling the Goalie on FLT3 Inhibitor Use in AML - A Discussion with Dr. Dale Bixby

    Közzétéve: 2022. 11. 23.

  8. Episode (3+)7: Straight Outta Roswell - OG AML Data

    Közzétéve: 2022. 10. 07.

  9. Episode 6: Dr. StrangeDrug or: How I Learned to Stop Worrying and Love the Asparaginase

    Közzétéve: 2022. 07. 21.

  10. Episode 5: IDH Inhibitors in AML: not so AGILE

    Közzétéve: 2022. 06. 03.

  11. Episode 4: All Aboard the Oncology StewardSHIP

    Közzétéve: 2022. 05. 27.

  12. Episode 3.2: Ranting About Rituximab in Acute Lymphoblastic Leukemia

    Közzétéve: 2022. 04. 22.

  13. Episode 3.1: History of Acute Lymphoblastic Leukemia Treatment and Building the BFM Backbone

    Közzétéve: 2022. 04. 22.

  14. Episode 2: We Don't Talk About Rylaze

    Közzétéve: 2022. 03. 18.

  15. Episode 1: Surrogate Endpoints in AML

    Közzétéve: 2022. 03. 11.

2 / 2

Welcome to WolverHeme Happy Hour! This is a podcast dedicated to all things hematology! We discuss new data, debate controversial therapies, and talk about new and exciting research. While we nerd out about data, we'll have a few drinks! Disclaimer: The views and opinions expressed on this podcast are solely those of the podcasters and guests and do not reflect the views or opinions of our employers or other affiliations.

Visit the podcast's native language site